391 related articles for article (PubMed ID: 30481609)
1. PARP family enzymes: regulation and catalysis of the poly(ADP-ribose) posttranslational modification.
Langelier MF; Eisemann T; Riccio AA; Pascal JM
Curr Opin Struct Biol; 2018 Dec; 53():187-198. PubMed ID: 30481609
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase enzymes and the maintenance of genome integrity.
Eisemann T; Pascal JM
Cell Mol Life Sci; 2020 Jan; 77(1):19-33. PubMed ID: 31754726
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of the poly(ADP-ribose) polymerase activity of tankyrase 1, a potential regulator of telomere length.
Rippmann JF; Damm K; Schnapp A
J Mol Biol; 2002 Oct; 323(2):217-24. PubMed ID: 12381316
[TBL] [Abstract][Full Text] [Related]
4. PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
van Beek L; McClay É; Patel S; Schimpl M; Spagnolo L; Maia de Oliveira T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066057
[TBL] [Abstract][Full Text] [Related]
5. Poly (ADP-Ribose) Polymerases (PARPs) and PARP Inhibitor-Targeted Therapeutics.
Li N; Wang Y; Deng W; Lin SH
Anticancer Agents Med Chem; 2019; 19(2):206-212. PubMed ID: 30417796
[TBL] [Abstract][Full Text] [Related]
6. Tankyrases as drug targets.
Lehtiö L; Chi NW; Krauss S
FEBS J; 2013 Aug; 280(15):3576-93. PubMed ID: 23648170
[TBL] [Abstract][Full Text] [Related]
7. Tankyrase-targeted therapeutics: expanding opportunities in the PARP family.
Riffell JL; Lord CJ; Ashworth A
Nat Rev Drug Discov; 2012 Dec; 11(12):923-36. PubMed ID: 23197039
[TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
[TBL] [Abstract][Full Text] [Related]
9. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
Lin KY; Huang D; Kraus WL
Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of selective inhibition of human tankyrases.
Narwal M; Venkannagari H; Lehtiö L
J Med Chem; 2012 Feb; 55(3):1360-7. PubMed ID: 22233320
[TBL] [Abstract][Full Text] [Related]
11. Tankyrase-1 overexpression reduces genotoxin-induced cell death by inhibiting PARP1.
Yeh TY; Sbodio JI; Nguyen MT; Meyer TN; Lee RM; Chi NW
Mol Cell Biochem; 2005 Aug; 276(1-2):183-92. PubMed ID: 16132700
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribosylation) and genomic stability.
Oei SL; Keil C; Ziegler M
Biochem Cell Biol; 2005 Jun; 83(3):263-9. PubMed ID: 15959554
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of poly(ADP-ribose) polymerase-1 in longevity.
Bürkle A; Brabeck C; Diefenbach J; Beneke S
Int J Biochem Cell Biol; 2005 May; 37(5):1043-53. PubMed ID: 15743677
[TBL] [Abstract][Full Text] [Related]
14. The antimitotic potential of PARP inhibitors, an unexplored therapeutic alternative.
Iglesias P; Costoya JA
Curr Top Med Chem; 2014; 14(20):2346-65. PubMed ID: 25434352
[TBL] [Abstract][Full Text] [Related]
15. ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification.
Rouleau-Turcotte É; Pascal JM
J Biol Chem; 2023 Dec; 299(12):105397. PubMed ID: 37898399
[TBL] [Abstract][Full Text] [Related]
16. The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport.
Abd Elmageed ZY; Naura AS; Errami Y; Zerfaoui M
Cell Signal; 2012 Jan; 24(1):1-8. PubMed ID: 21840394
[TBL] [Abstract][Full Text] [Related]
17. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors.
Thorsell AG; Ekblad T; Karlberg T; Löw M; Pinto AF; Trésaugues L; Moche M; Cohen MS; Schüler H
J Med Chem; 2017 Feb; 60(4):1262-1271. PubMed ID: 28001384
[TBL] [Abstract][Full Text] [Related]
18. Tankyrase polymerization is controlled by its sterile alpha motif and poly(ADP-ribose) polymerase domains.
De Rycker M; Price CM
Mol Cell Biol; 2004 Nov; 24(22):9802-12. PubMed ID: 15509784
[TBL] [Abstract][Full Text] [Related]
19. Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2.
Qiu W; Lam R; Voytyuk O; Romanov V; Gordon R; Gebremeskel S; Vodsedalek J; Thompson C; Beletskaya I; Battaile KP; Pai EF; Rottapel R; Chirgadze NY
Acta Crystallogr D Biol Crystallogr; 2014 Oct; 70(Pt 10):2740-53. PubMed ID: 25286857
[TBL] [Abstract][Full Text] [Related]
20. [Role of PARP and protein poly-ADP-ribosylation process in regulation of cell functions].
Drel' VR; Shymans'kyĭ IO; Sybirna NO; Velykyĭ MM
Ukr Biokhim Zh (1999); 2011; 83(6):5-34. PubMed ID: 22364016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
